Author: Nicole

KM Steele, ME Munger, KM Peters, BR Shuman, MH Schwartz (2019) “Repeatability of electromyography recordings and muscle synergies during gait among children with cerebral palsy.” Gait & Posture

Nicole JournalArticle, MotorControl, Projects, Publications , , , , ,

Journal Article in Gait & Posture:

Repeatability of EMG is similar between typically developing children and children with cerebral palsy.

Background: Clinical gait analysis is commonly used in the evaluation and treatment of children with cerebral palsy (CP). While the repeatability of kinematic and kinetic measures of gait has previously been evaluated, the repeatability of electromyography (EMG) recordings or measures calculated from EMG data, such as muscle synergies, remains unclear for this population.

Research Question: Are EMG recordings and muscle synergies from clinical gait analysis repeatable between visits for children with CP?

Methods: We recruited 20 children with bilateral CP who had been referred for clinical gait analysis. The children completed two visits less than six weeks apart with EMG data collected bilaterally from five muscles (rectus femoris, medial hamstrings, vastus lateralis, anterior tibialis, and medial gastrocnemius). Variance ratio and cosine similarity were used to evaluate repeatability of EMG waveforms between visits. Nonnegative matrix factorization was used to calculate synergies from EMG data at each visit to compare synergy weights and activations.

Results & significance: The inter-visit variance ratios of EMG data for children with CP were similar to previously reported results for typically-developing children and unimpaired adults (range: 0.39 for vastus lateralis to 0.66 for rectus femoris). The average cosine similarity of the EMG waveforms between visits was greater than 0.9 for all muscles, while synergy weights and activations also had high similarity – greater than 0.8 and 0.9 between visits, respectively. These results demonstrate that EMG repeatability between visits during clinical gait analysis for children with CP is similar to unimpaired individuals. These results provide a baseline for evaluating whether observed changes in EMG recordings between visits reflect real changes in muscle activity or are within the range of inter-visit variability.

BR Shuman, M Goudriaan, K Desloovere, MH Schwartz, KM Steele (2018) “Associations Between Muscle Synergies and Treatment Outcomes in Cerebral Palsy Are Robust Across Clinical Centers.” Archives of Physical Medicine and Rehabilitation

Nicole JournalArticle, MotorControl, Projects, Publications , , , , ,

Journal article in Archives of Physical Medicine and Rehabilitation:

In collaboration with Gillette Children’s Hospital and University Hospital Pellenberg we examined whether associations between treatment outcomes and muscles synergies are robust between clinical centers.

Objective: To determine whether patient-specific differences in motor control quantified using muscle synergy analysis were associated with changes in gait after treatment of cerebral palsy (CP) across 2 clinical centers with different treatments and clinical protocols.
Design: Retrospective cohort study.
Setting: Clinical medical center.
Participants: Center 1: children with CP (n=473) and typically developing (TD) children (n=84). Center 2: children with CP (n=163) and TD children (n=12).
Interventions: Standard clinical care at each center.
Main outcome measures: The Dynamic Motor Control Index During Walking (walk-DMC) was computed from electromyographic data during gait using muscle synergy analysis. Regression analysis was used to evaluate whether pretreatment walking speed or kinematics, muscle synergies, treatment group, prior treatment, or age were associated with posttreatment changes in gait at both clinical centers.
Results: Walk-DMC was significantly associated with changes in speed and kinematics after treatment with similar regression models at both centers. Children with less impaired motor control were more likely to have improvements in walking speed and gait kinematics after treatment, independent of treatment group.
Conclusions: Dynamic motor control evaluated with synergy analysis was associated with changes in gait after treatment at both centers, despite differences in treatments and clinical protocols. This study further supports the finding that walk-DMC provides additional information, not captured in traditional gait analysis, that may be useful for treatment planning.

M Goudriaan, BR Shuman, KM Steele, M Van den Hauwe, N Goemans, G Molenaers, K Desloovere (2018) “Non-neural Muscle Weakness Has Limited Influence on Complexity of Motor Control during Gait.” Frontiers in Human Neuroscience

Nicole JournalArticle, MotorControl, Projects, Publications , , , , ,

Journal Article in Frontiers in Human Neuroscience:

Despite significant differences in kinematics children with Duchenne muscular dystrophy have similar control complexity to typically developing children.

Abstract: Cerebral palsy (CP) and Duchenne muscular dystrophy (DMD) are neuromuscular disorders characterized by muscle weakness. Weakness in CP has neural and non-neural components, whereas in DMD, weakness can be considered as a predominantly non-neural problem. Despite the different underlying causes, weakness is a constraint for the central nervous system when controlling gait. CP demonstrates decreased complexity of motor control during gait from muscle synergy analysis, which is reflected by a higher total variance accounted for by one synergy (tVAF1). However, it remains unclear if weakness directly contributes to higher tVAF1 in CP, or whether altered tVAF1 reflects mainly neural impairments. If muscle weakness directly contributes to higher tVAF1, then tVAF1 should also be increased in DMD. To examine the etiology of increased tVAF1, muscle activity data of gluteus medius, rectus femoris, medial hamstrings, medial gastrocnemius, and tibialis anterior were measured at self-selected walking speed, and strength data from knee extensors, knee flexors, dorsiflexors and plantar flexors, were analyzed in 15 children with CP [median (IQR) age: 8.9 (2.2)], 15 boys with DMD [8.7 (3.1)], and 15 typical developing (TD) children [8.6 (2.7)]. We computed tVAF1 from 10 concatenated steps with non-negative matrix factorization, and compared tVAF1between the three groups with a Mann-Whiney U-test. Spearman’s rank correlation coefficients were used to determine if weakness in specific muscle groups contributed to altered tVAF1. No significant differences in tVAF1 were found between DMD [tVAF1: 0.60 (0.07)] and TD children [0.65 (0.07)], while tVAF1 was significantly higher in CP [(0.74 (0.09)] than in the other groups (both p < 0.005). In CP, weakness in the plantar flexors was related to higher tVAF1 (r = −0.72). In DMD, knee extensor weakness related to increased tVAF1 (r = −0.50). These results suggest that the non-neural weakness in DMD had limited influence on complexity of motor control during gait and that the higher tVAF1 in children with CP is mainly related to neural impairments caused by the brain lesion.